Total knee arthroplasty in hemophilic arthropathy: efficiency of clotting factor usage in multijoint procedures.
Schild
F J A
FJ
Mauser-Bunschoten
E P
EP
Verbout
A J
AJ
Van Rinsum
A C
AC
Roosendaal
G
G
D000328:Adult; D000368:Aged; D000843:Ankle Joint / Q000601:surgery; D001174:Arthrodesis / Q000191:economics; D019644:Arthroplasty, Replacement, Hip / Q000191:economics; D019645:Arthroplasty, Replacement, Knee / Q000191:economics; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D017046:Cost Savings; D004363:Drug Utilization; D005260:Female; D006395:Hemarthrosis / Q000209:etiology / Q000601:surgery*; D006467:Hemophilia A / Q000150:complications*; D002836:Hemophilia B / Q000150:complications*; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000517:prevention & control; D012189:Retrospective Studies
D001779:Blood Coagulation Factors